Phase II Interstitial Brachytherapy Combined With Androgen Deprivation Therapy [bicalutamide + leuprorelin] for Locally Recurrent Prostate Cancer After Prior External Beam Irradiation.

Trial Profile

Phase II Interstitial Brachytherapy Combined With Androgen Deprivation Therapy [bicalutamide + leuprorelin] for Locally Recurrent Prostate Cancer After Prior External Beam Irradiation.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Nov 2012

At a glance

  • Drugs Bicalutamide (Primary) ; Leuprorelin (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 May 2011 Planned end date changed from 1 Apr 2025 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 13 May 2011 Planned end date changed from 1 Apr 2025 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 18 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top